TRUTAG TECHNOLOGIES, INC.

Profile

Company Names

TRUTAG TECHNOLOGIES, INC.

Addresses

2200 POWELL STREET #1035, EMERYVILLE, CA 94608

2200 POWELL STREET, #1035, EMERYVILLE, CA 94608

650 IWILEI ROAD, SUITE 250, HONOLULU, HI 96817

Phone Numbers

(510) 879-6408
(808) 878-8247
650-843-5918

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$56,940,212.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-11-12 
$14,692,572.00 
$24,242,588.00 
$9,550,016.00 
Equity 
2
2019-08-22 
$25,471,113.00 
$43,055,938.00 
$17,584,825.00 
Equity 
1
2012-10-11 
$16,776,527.00 
$17,413,518.00 
$636,991.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GEORGE 
 
ARIYOSHI 
DIRECTOR
TRUTAG TECHNOLOGIES, INC.   |  CBI POLYMERS, INC.
MICHAEL 
 
BARTHOLOMEUSZ 
EXECUTIVE OFFICER, DIRECTOR
AQT SOLAR, INC.   |  HZO, INC.   |  TRUTAG TECHNOLOGIES, INC.
MATTHEW 
 
COHEN 
DIRECTOR
LATITUDE SOLUTIONS, INC.   |  TRIQ, INC.   |  IMPACT DIRECTLY PBC   |  NITROUS FUNDING LLC   |  INVEST FORWARD, INC.   |  SUREPORT HOLDINGS INC.   |  IMMVENTION THERAPEUTIX, INC.   |  TRUTAG TECHNOLOGIES, INC.   |  RIPPLE VENTURES 11-21 L.P. (WISEDOCS)   |  RIPPLE CAPITAL 02-21 L.P. (UDACITY)   |  RIPPLE VENTURES 11-19 L.P. (TREAD)   |  RIPPLE VENTURES SPECIAL OPPORTUNITIES FUND I LP   |  RIPPLE VENTURES 10-20 L.P. (ROSE ROCKET)   |  RIPPLE VENTURES 08-20 L.P. (ONCALL)   |  RIPPLE VENTURES FUND III LP   |  RIPPLE VENTURES FUND I, LP   |  OSAGE UNIVERSITY PARTNERS IV, LP   |  OUP IV AFF PARTNERSHIP, LP   |  TRANSAERA, INC.   |  ALPHINA THERAPEUTICS, INC.
SEAN 
 
KARAMCHANDANI 
DIRECTOR
PERSISTENCE CAPITAL PARTNERS III (INTERNATIONAL), L.P.   |  TRUTAG TECHNOLOGIES, INC.
LESLIE 
 
LEFF 
DIRECTOR
TRUTAG TECHNOLOGIES, INC.
GREGORY 
 
LEONG 
DIRECTOR
TRUTAG TECHNOLOGIES, INC.
MARK 
 
MACIEJEWSKI 
DIRECTOR
LONESTAR HEART, INC.   |  TRUTAG TECHNOLOGIES, INC.
KENT 
 
MANSFIELD 
EXECUTIVE OFFICER
TRUTAG TECHNOLOGIES, INC.
JENNIFER 
 
MCFARLANE 
DIRECTOR
ZYOMYX INC   |  BLUE PLANET SYSTEMS CORP   |  TRUTAG TECHNOLOGIES, INC.   |  EMRGY INC.
MICHAEL 
 
O-NEILL, PH.D. 
EXECUTIVE OFFICER
TRUTAG TECHNOLOGIES, INC.
JAMES 
 
PAPPAS 
DIRECTOR
IBIS NETWORKS, INC.   |  TRUTAG TECHNOLOGIES, INC.   |  RED ROCK TELECOMMUNICATIONS, INC.
ALBERT 
 
PLEUS 
DIRECTOR
KUEHNLE AGROSYSTEMS INC   |  GROWER-S SECRET, INC.   |  PROTEUS BIOAG HOLDINGS, LLC   |  GSI HOLDINGS, LLC   |  GSI HOLDINGS II, LLC   |  VERDANT MARKETING + RESEARCH, INC.   |  TRUTAG TECHNOLOGIES, INC.
JEFFREY 
 
WATANABE 
DIRECTOR
TISSUE GENESIS INC   |  TRUTAG TECHNOLOGIES, INC.   |  CBI POLYMERS, INC.   |  CELLULAR BIOENGINEERING INC
BARRY 
 
WEINMAN 
DIRECTOR
HOANA MEDICAL INC   |  TRUTAG TECHNOLOGIES, INC.   |  PENNTEX OPPORTUNITIES I, L.P.   |  PENNTEX OPPORTUNITIES III, LP
PETER 
M. O. 
WONG 
EXECUTIVE OFFICER
TRUTAG TECHNOLOGIES, INC.
HANK 
C.K. 
WUH, M.D. 
EXECUTIVE OFFICER, DIRECTOR
TRUTAG TECHNOLOGIES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-11-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-12 
2019-09-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-22 
2014-06-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-11 
2012-10-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-11 
2012-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BEDMINSTER FINANCIAL GROUP, LTD.
39916